Table 3.
Gene | N studies | Severe disease | Not severe disease | OR (95% CI) | p | I2 | ||
---|---|---|---|---|---|---|---|---|
Events | Total | Events | Total | |||||
ACE1_rs4646994_rs1799752 | ||||||||
DD | 15 | 422 | 1223 | 565 | 1977 | 1.61 (1.21–2.14) | 0.001 | 60% |
DI | 13 | 484 | 1155 | 815 | 1855 | 0.87 (0.68–1.11) | 0.27 | 50% |
II | 15 | 273 | 1223 | 511 | 1977 | 0.67 (0.49–0.93) | 0.02 | 55% |
ACE2_rs2285666 | ||||||||
GG | 4 | 290 | 480 | 284 | 454 | 1.47 (0.77–2.80) | 0.24 | 62% |
AG | 4 | 64 | 105 | 0.51 (0.35–0.74) | 0.0005 | 0% | ||
AA | 4 | 126 | 65 | 0.89 (0.31–2.54) | 0.83 | 61% | ||
IFTM3_rs12252 | ||||||||
CC | 4 | 16 | 332 | 21 | 782 | 2.26 (1.05–4.89) | 0.04 | 0% |
CT | 4 | 41 | 97 | 1.00 (0.67–1.49) | 0.98 | 39% | ||
TT | 4 | 275 | 664 | 0.82 (0.55–1.21) | 0.32 | 0% | ||
TMPRSS2_rs12329760 | ||||||||
CC | 4 | 145 | 384 | 367 | 749 | 0.92 (0.45–1.91) | 0.83 | 83% |
CT | 4 | 172 | 302 | 1.04 (0.68–1.59) | 0.86 | 54% | ||
TT | 4 | 67 | 80 | 0.93 (0.46–1.87) | 0.84 | 41% | ||
TNFα_rs1800629 | ||||||||
AA | 5 | 420 | 896 | 125 | 752 | 1.91 (0.44–8.32) | 0.39 | 94% |
GA | 5 | 316 | 292 | 0.87 (0.58–1.3) | 0.50 | 61% | ||
GG | 5 | 160 | 335 | 0.36 (0.07–1.75) | 0.20 | 95% |
Meta-analyses with p < 0.005 are in bold